Asia-Pacific Inhalable Drugs Market Trends, Size, Competitive Analysis and Forecast 2020-2026
The Asia-Pacific inhalable drug market is anticipated to grow at a CAGR of 5.1% over the forecast period (2020-2026). The key factors that drive the growth of the market include the rising prevalence of asthmatic patients across the region, especially in China. The increased demand for advanced healthcare facilities in emerging economies of the region along with the increasing focus of major market players towards the development of innovative products are the prominent factors that are significantly contributing to the inhalable drug industry growth.
To Request a Sample of our Report on Asia-Pacific
Inhalable Drugs Market: https://www.omrglobal.com/request-sample/asia-pacific-inhalable-drugs-market
Asia-Pacific comprises large low- and middle-income
population base, owing to which, the people generally adopt home-based care
solutions. This, in turn, accelerates the growth of the inhalable drugs as home
care solutions for asthmatic patients in the region.
Moreover, the rising healthcare spending in the
emerging economies of the region is expected to provide the medical solution to
the poor healthcare infrastructure of some countries in the region. Besides,
some other factors that drive the market growth in the region are the wide
availability of inhalable drug products. Further, the increased geriatric
population in countries such as China and Japan also supports market growth as
these inhalable drugs are easier for an elder patient in comparison with other
traditional methods such as swallowing a pill or injecting. This further aids
the growth of the inhalable drug market in the region over the forecast
period.
Market Coverage
·
Market number available for – 2019-2026
·
Base year- 2019
·
Forecast period- 2020-2026
·
Segment Covered- By Application and By Route of
Administration
·
Regions Covered- Asia-Pacific
·
Competitive Landscape- Johnson & Johnson Services
Inc., Teva Pharmaceuticals Industries Ltd., Sumitomo Dainippon Pharma Co. Ltd.,
Mylan NV, and Cipla Ltd
Key questions addressed by the report
·
What is the market growth rate?
·
Which segment/ country dominates the market in the base
year?
·
Which segment/ country will project the fastest growth in
the market?
·
How COVID-19 impacted the market?
·
Recovery Timeline
·
Deviation from the pre-COVID-19 forecast
·
Most affected segment/ country
·
Who is the leader in the market?
·
How players are addressing challenges to sustain growth?
·
Where is the investment opportunity?
(Get 15% Discount on Buying this Report)
A
full Report of Asia-Pacific Inhalable Drugs Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-inhalable-drugs-market
Asia-Pacific Inhalable Drugs Market – Segmentation
By Application
·
Respiratory Diseases
·
Non- Respiratory Diseases
By Route of Administration
·
Nasal
·
Mouth
Asia-Pacific Inhalable Drugs Market – Countries Covered
·
China
·
India
·
Japan
Rest of Asia-Pacific
Competitive Landscape
·
AstraZeneca Plc
·
Overview
·
AstraZeneca Plc in Asia-Pacific
·
AstraZeneca Plc in Inhalable Drugs Landscape
·
Recent Developments
·
Cipla Ltd.
·
GlaxoSmithKline Plc
·
Johnson & Johnson Services Inc.
·
Medisol Lifescience Pvt. Ltd.
·
Mylan NV
·
Novartis AG
·
Pfizer Inc.
·
Sanofi SA
·
Sumitomo Dainippon Pharma Co. Ltd.
·
Teicos Pharma Ltd.
·
Teva Pharmaceutical Industries Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-inhalable-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment